Advanced search×

Development and implementation of a pharmacist-managed clinical pharmacogenetics service.

Am J Health Syst Pharm 68(2):143-50 (2011) PMID 21200062 PMCID PMC3228517

The development and implementation of a pharmacist-managed clinical pharmacogenetics service are described.

DOI: 10.2146/ajhp100113
Version: za2963e q8za6 q8zbf q8zc7 q8zd8 q8zed q8zf8 q8zgb

Similar articles you may find interesting…

  1. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: Review and meta-analysis.

    Am J Health Syst Pharm 68(3):241-53 (2011) PMID 21258029

    Purpose Pharmacist interventions to enhance blood pressure (BP) control and adherence to antihypertensive therapy in adults with essential hypertension were reviewed. Methods A literature search was conducted to identify relevant articles describing pharmacist interventions intended...
  2. Identification of drug interactions in hospitals--computerized screening vs. bedside recording.

    J Clin Pharm Ther 33(2):131-9 (2008) PMID 18315778

    Among 827 patients, computer screening identified DDIs in 544 patients (66%); 351 had DDIs introduced in hospital. The 1513 computer-identified DDIs had the following distribution: type A 78; type B 915; type C 38; type D 482. By bedside evaluation, 99 DDIs were identified in 73 patients (9%). The p...
  3. Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy.

    Am J Med 118(12):1414 (2005) PMID 16378791

    Structured care delivered by a pharmacist-diabetes specialist team reduced the incidence of end-stage renal disease or death compared with usual care in patients with type 2 diabetic nephropathy....